<DOC>
	<DOC>NCT00544921</DOC>
	<brief_summary>To test the safety of GLY-230 and to evaluate how long drug stays in blood after taking it by mouth.</brief_summary>
	<brief_title>Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Men age 1855 Negative drug screen Normal EKG, clinical chemistries, CBC, urinalysis, and Give written informed consent Active concomitant serious medical or surgical disease, Hepatic or renal laboratory values above reference range, ise of other experimental drug within previous 30 days</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>